Clinical Trial Update: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating synthetic ACTH in high-risk patients with idiopathic membranous nephropathy has completed. The study was sponsored by Radbou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy

Drugs mentioned

• Synthetic ACTH (cosyntropin) (cosyntropin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Idiopathic Membranous Nephropathy | Phase 2 | Status: COMPLETED